Cargando…
Decrease in heart rate following the administration of sugammadex in adults
BACKGROUND AND AIMS: Sugammadex is a novel agent for reversal of steroidal neuromuscular blocking agents (NMBAs) with potential advantages over acetylcholinesterase inhibitors. In preclinical trials, there have been rare instances of bradycardia with progression to cardiac arrest. To better define t...
Autores principales: | Sims, Trent, Peterson, Joshua, Hakim, Mohammed, Roth, Catherine, Tumin, Dmitry, Tobias, Joseph D., Hansen, Jennifer K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022043/ https://www.ncbi.nlm.nih.gov/pubmed/33840924 http://dx.doi.org/10.4103/joacp.JOACP_346_19 |
Ejemplares similares
-
Heart Rate Changes Following the Administration of Sugammadex to Infants and Children With Comorbid Cardiac, Cardiovascular, and Congenital Heart Diseases
por: Arends, Jordan, et al.
Publicado: (2020) -
Use of Sugammadex in a Patient With Myotonic Dystrophy
por: Ahmed, Samira, et al.
Publicado: (2018) -
Monitoring of Sugammadex Dosing at a Large Tertiary Care Pediatric Hospital
por: Syed, Faizaan, et al.
Publicado: (2018) -
Age-Dependent Impact of Pre-Transplant Intensive Care Unit Stay on Mortality in Heart Transplant Recipients
por: Sims, Trent, et al.
Publicado: (2019) -
A rare case of atropine-resistant bradycardia following sugammadex administration
por: Yoshida, Takayuki, et al.
Publicado: (2020)